2 / 12
Volume 7, Issue 5 (Suppl)
Epidemiology (Sunnyvale), an open access journal
ISSN: 2161-1165
Epidemiology 2017
October 23-25, 2017
Page 20
conference
series
.com
EPIDEMIOLOGY & PUBLIC HEALTH
October 23-25, 2017 | Paris, France
6
th
International Conference on
Ray M Merrill, Epidemiology (Sunnyvale) 2017, 7:5(Suppl)
DOI: 10.4172/2161-1165-C1-016
CONDITIONAL SURVIVAL AMONG FEMALE BREAST CANCER PATIENTS IN THE
UNITED STATES
T
he relative cancer survival rate may be more meaningful to patients because it indicates the chance they will not die from
the specific disease. This measure can be further tailored to patients by updating it according to time already survived and
for selected personal characteristics. In the current study, conditional relative survival for female breast cancer is presented,
based on cases diagnosed during 2000-2008 and followed up through 2013, using population-based data from the Surveillance,
Epidemiology and End Results (SEER) program of the National Cancer Institute. Five-year relative survival improved from
89% at diagnosis to 93% (4.9%) for patients who had already survived 5 years. Five-year relative survival was 98% for local
disease, 85% regional disease, and 30% for distant disease; 100% for Grade I, 94% for Grade II, 81% for Grade III, and 80% for
Grace IV; 90% for Whites, 78% for Blacks, 82% for American Indians/Alaska Natives, and 91% for Asians; and 93% for married
and 85% for singles. Improvement in 5-year relative survival from diagnosis to five years already survived was -1.1% for local
disease, 3.2% regional disease, and 91.4% for distant disease; -0.9% for Grade I, -0.7% for Grade II, 11.4% for Grade III, and
14.2% for Grace IV; 3.9% for Whites, 13.4% for Blacks, 8.8% for American Indians/Alaska Natives, and 3.5% for Asians; and
2.8% for married and 6.8% for singles. Age and ethnicity had little influence on conditional relative survival. The association
between 5-year relative survival and time already survived within stage groups remains similar after adjusting for age, race,
ethnicity, marital status, and tumour grade.
Biography
Ray Merrill is a Professor in the Department of Health Science at Brigham Young University. He joined the faculty in 1998, following employment as a Mathematical
Statistician in theApplied Research Branch at the National Cancer Institute. His research interests include chronic disease epidemiology, social determinants of health and
program planning and evaluation.
Ray_Merrill@byu.eduRay MMerrill
Brigham Young University, USA